Bortezomib 2mg Injection (Bortemib) is an anti-cancer (chemotherapy) medication widely used in the treatment of multiple myeloma and mantle cell lymphoma. It belongs to the class of proteasome inhibitors and works by slowing or stopping the growth of cancer cells in the body.
π Manufacturer & Global Exporter
Cordium Pharmaceuticals Pvt Ltd is a trusted global exporter of high-quality pharmaceutical injections from India, ensuring reliable supply and fast international delivery across multiple countries including:
United States πΊπΈ
United Kingdom π¬π§
Germany π©πͺ
Netherlands π³π±
United Arab Emirates π¦πͺ
South Africa πΏπ¦
Brazil π§π·
π Usage of Bortezomib 2mg Injection
Bortezomib Injection is commonly prescribed for:
Multiple Myeloma (Blood Cancer)
Mantle Cell Lymphoma
Cancer relapse therapy
Combination chemotherapy protocols (as advised by oncologists)
β οΈ Dosage Information
The dosage of Bortezomib 2mg Injection is strictly determined by an oncologist based on:
Patient body weight
Medical condition
Treatment cycle response
π It is administered by a healthcare professional either intravenously or subcutaneously. Self-administration is strictly not recommended.
β οΈ Side Effects
Some possible side effects may include:
Nausea and vomiting
Fatigue and weakness
Low blood platelet count
Peripheral neuropathy (tingling or numbness)
Fever or infection risk
Loss of appetite
π Patients should always follow medical supervision during treatment.
π Global Export & Fast Delivery
Cordium Pharmaceuticals Pvt Ltd ensures:
GMP-WHO certified supply chain
Safe pharmaceutical packaging
Fast international export logistics
Bulk supply availability for hospitals, distributors & wholesalers
π Contact for Bulk Orders & Export Inquiry
π± WhatsApp: +91-9405117673
π§ Email: info@cordiumpharma.com
